Bayabao, Alaizah D.

HRN: 21-95-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2022
MUPIROCIN 2%, 15G (TUBE)
10/28/2022
11/04/2022
IV
Topical
Tid
Pcap D, T/c Parapneumonic Effusion Vs Tb
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: